Biotech

All Articles

Lilly, Haya ink $1B biobuck weight problems treaty to browse black genome

.Eli Lilly's hunt for being overweight aim ats has led it to the dark genome. The Big Pharma has put...

ArsenalBio raises $325M, rotates far from past lead property

.Arsenal Biosciences is moving on up. The cell therapy firm has actually added on $325 thousand in a...

Lilly- supported weight-loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...

Aelis' cannabis usage medicine fails period 2b, driving Indivior to re-think $100M alternative

.Aelis Farma's hopes of getting a quick, favorable choice on a $one hundred million option payment h...

ProKidney halts phase 3 trial not required for tissue treatment approval

.ProKidney has ceased one of a pair of phase 3 trials for its own cell treatment for kidney illness ...

Vaxcyte rises on 'impressive' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what professionals referred to as "stunning" stage 1/2 data for its own 31-valent ...

Recursion's mind illness test presents insufficient documentation of effectiveness

.Recursion has actually stumbled by means of a very early exam of its tech-enabled method to medicin...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Phone it a situation of great chemistry: Acepodia, a biotech based on Nobel Prize-winning science, ...

Praxis epilepsy medication lessens confiscations in phase 2 litigation

.Praxis Accuracy Medicines has actually scored one more midphase succeed in epilepsy this year, with...

Three directors resign as Dyne posts mixed data for DMD applicant

.After getting away a medical grip several years back, Dyne Rehab has revealed brand new phase 1/2 i...